Illumina, Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications i…
Medical - Diagnostics & Research
US, San Diego [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 69.12 | 66.63 | 67.18 | 67.35 | 64.16 | 69.72 | 69.80 | 69.48 | 66.35 | 69.01 | 69.63 | 68.01 | 69.69 | 64.83 | 61.06 | |
| Profit Margin | 10.85 | 13.83 | 8.21 | 13.17 | 8.82 | 18.98 | 20.79 | 19.29 | 26.38 | 24.78 | 28.28 | 20.25 | 16.84 | -96.07 | -25.78 | |
| Operating Margin | 18.85 | 23.45 | 18.90 | 17.48 | 9.44 | 27.65 | 27.61 | 24.48 | 22.02 | 26.49 | 27.80 | 17.91 | -2.72 | -91.16 | -1.55 | |
|
EPS Growth
|
37.21 | 71.19 | -30.69 | 75.71 | -18.70 | 161.00 | 21.84 | -0.94 | 57.78 | 13.08 | 21.35 | -34.60 | 13.90 | -652.17 | 73.80 | |
| EPS USD | 59.00 | 101.00 | 70.00 | 123.00 | 100.00 | 261.00 | 318.00 | 315.00 | 497.00 | 562.00 | 682.00 | 446.00 | 508.00 | -2,805.00 | -735.00 | |
| Return on Assets (ROA) | 5.05 | 6.79 | 3.95 | 5.89 | 4.15 | 10.59 | 12.52 | 10.81 | 13.81 | 11.87 | 13.70 | 8.65 | 5.01 | -35.95 | -11.48 | |
| Return on Equity (ROE) | 8.36 | 10.43 | 8.06 | 11.47 | 8.17 | 24.16 | 24.97 | 20.38 | 25.53 | 21.48 | 21.72 | 13.98 | 7.09 | -66.74 | -20.21 | |
| Return on Invested Capital (ROIC) | 6.89 | 9.45 | 6.90 | 6.31 | 4.39 | 14.72 | 16.35 | 12.64 | 9.42 | 13.22 | 13.43 | 6.79 | -0.80 | -42.12 | -0.99 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 20.30 | 16.94 | 36.77 | 32.83 | 28.77 | 38.68 | 29.57 | 29.71 | 25.41 | 28.70 | 25.71 | 24.46 | 16.69 | 28.40 | 15.58 | |
| Debt/Equity | 33.58 | 26.02 | 75.09 | 63.89 | 56.65 | 88.26 | 59.00 | 56.02 | 46.98 | 51.94 | 40.78 | 39.52 | 23.65 | 52.72 | 27.42 | |
| Debt/EBITDA | 93.96 | 26.34 | 177.61 | 130.78 | 41.96 | 176.03 | 50.81 | 94.09 | 18.32 | 96.60 | -20.91 | 7.76 | -1,005.69 | 30.04 | 335.36 | |
|
Debt/Capitalization
|
25.14 | 20.65 | 42.89 | 38.98 | 36.16 | 46.88 | 37.11 | 35.91 | 31.96 | 34.18 | 28.97 | 28.32 | 19.13 | 34.52 | 21.52 | |
| Long-Term Debt/Capitalization | - - | - - | 42.89 | 37.92 | 35.38 | 40.28 | 35.46 | 31.58 | 29.36 | 18.80 | 28.47 | 22.26 | 18.69 | 25.27 | 20.58 | |
| Interest Debt per Share USD | 2.55 | 2.72 | 6.82 | 7.16 | 7.26 | 9.83 | 7.81 | 8.88 | 9.40 | 13.97 | 13.15 | 12.95 | 17.34 | 22.32 | 10.46 | |
| Debt Growth | -27.45 | 7.38 | 159.10 | 4.34 | 3.11 | 48.64 | -15.53 | 16.62 | 5.05 | 49.48 | -8.06 | 1.04 | 33.10 | 40.91 | -34.98 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 222.46 | 235.43 | 650.15 | 586.74 | 502.24 | 261.71 | 343.46 | 328.96 | 399.46 | 248.89 | 669.32 | 360.37 | 248.22 | 128.42 | 166.18 | |
| Quick Ratio | 192.93 | 198.29 | 573.89 | 513.90 | 436.11 | 225.41 | 290.22 | 275.31 | 342.63 | 223.17 | 599.55 | 318.25 | 181.79 | 97.66 | 115.03 | |
| Cash Ratio | 32.78 | 46.57 | 127.53 | 142.49 | 220.96 | 88.09 | 125.93 | 104.24 | 164.21 | 63.41 | 307.07 | 145.50 | 112.72 | 72.52 | 66.75 | |
| Operating Cash Flow Ratio | - - | - - | 100 | - - | 100 | - - | 100 | - - | 100 | - - | 100 | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 221.79 | 211.80 | 269.01 | 236.26 | 330.50 | 294.88 | 247.61 | 243.84 | 278.08 | 267.62 | 299.72 | 278.50 | 318.33 | 283.80 | 298.81 | |
| Receivables Turnover | 422.39 | 545.14 | 607.03 | 534.26 | 594.77 | 643.05 | 575.77 | 628.97 | 669.59 | 648.44 | 618.33 | 665.09 | 698.46 | 683.16 | 598.94 | |
| Payables Turnover | 389.85 | 451.28 | 695.57 | 570.52 | 691.46 | 682.17 | 481.57 | 530.65 | 578.75 | 561.41 | 722.15 | 539.58 | 413.25 | 550.17 | 715.92 | |
|
Asset Turnover
|
46.60 | 49.09 | 48.07 | 44.76 | 47.07 | 55.77 | 60.19 | 56.03 | 52.35 | 47.89 | 48.43 | 42.70 | 29.74 | 37.41 | 44.55 | |
| Fixed Turnover | 568.59 | 695.09 | 735.65 | 691.18 | 701.24 | 701.70 | 647.74 | 336.22 | 295.60 | 310.05 | 245.36 | 222.76 | 266.86 | 262.84 | 290.39 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 529.54 | 860.45 | 573.33 | 531.39 | 337.89 | 1,233.49 | 1,454.95 | 1,769.18 | 1,637.84 | 1,549.12 | 1,894.23 | 1,183.67 | -201.64 | -16,073.08 | -90.91 | |
| Asset Coverage | 400 | 400 | 200 | 200 | 200 | 200 | 200 | 200 | 300 | 300 | 300 | 300 | 400 | 200 | 200 | |
| Cash Flow Coverage (CFGR) | 60.13 | 87.47 | 44.36 | 34.65 | 44.49 | 38.83 | 60.48 | 54.04 | 65.49 | 57.19 | 55.87 | 58.22 | 21.46 | 11.27 | 30.29 | |
| EBITDA Coverage | 600 | 900 | 800 | 800 | 900 | 800 | 1,500 | 1,700 | 1,600 | 1,500 | 1,800 | 1,100 | -200 | 18,700 | 400 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | - - | 100 | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | 1.98 | 1.62 | 2.37 | 2.28 | 0.94 | 1.42 | 1.81 | 2.53 | 2.34 | 1.93 | 2.14 | 1.25 | 1.37 | -14.28 | -5.43 | |
|
Price/Earnings (P/E)
|
5,058.65 | 6,187.41 | 4,219.28 | 4,392.88 | 10,690.17 | 7,065.92 | 5,534.43 | 3,953.58 | 4,270.20 | 5,187.36 | 4,678.47 | 8,008.81 | 7,286.22 | -700.51 | -1,841.56 | |
| Price/Earnings Growth (PEG) | 135.95 | 86.92 | -137.47 | 58.02 | -571.69 | 43.89 | 253.42 | -4,190.80 | 73.91 | 396.63 | 219.11 | -231.44 | 524.14 | 1.07 | 24.95 | |
|
Price/Book (P/B)
|
423.08 | 645.21 | 339.94 | 503.91 | 873.70 | 1,706.83 | 1,381.87 | 805.70 | 1,090.07 | 1,114.37 | 1,016.22 | 1,119.25 | 516.96 | 467.50 | 372.16 | |
| Price/Tangible Book (P/TB) | 423.08 | 645.21 | 339.94 | 503.91 | 873.70 | 1,706.83 | 1,381.87 | 805.70 | 1,090.07 | 1,114.37 | 1,016.22 | 1,119.25 | 516.96 | 467.50 | 372.16 | |
| Price/Sales (P/S) | 548.75 | 856.01 | 346.28 | 578.52 | 942.57 | 1,341.36 | 1,150.78 | 762.65 | 1,126.51 | 1,285.56 | 1,323.12 | 1,622.04 | 1,226.71 | 673.00 | 474.70 | |
|
Price/Cash Flow (P/CF)
|
2,095.43 | 2,835.03 | 1,020.57 | 2,276.47 | 3,466.59 | 4,980.84 | 3,872.77 | 2,661.55 | 3,543.04 | 3,751.98 | 4,460.35 | 4,864.61 | 10,187.34 | 7,870.03 | 4,482.30 | |
| Price/Free CF (P/FCF) | 3,065.58 | 3,575.82 | 1,311.99 | 3,151.04 | 4,527.66 | 6,953.67 | 4,947.17 | 4,398.44 | 5,506.51 | 5,064.72 | 5,567.49 | 5,896.50 | 16,475.07 | -41,689.86 | 7,608.74 | |
| Price/Operating CF (P/OCF) | 2,095.43 | 2,835.03 | 1,020.57 | 2,276.47 | 3,466.59 | 4,980.84 | 3,872.77 | 2,661.55 | 3,543.04 | 3,751.98 | 4,460.35 | 4,864.61 | 10,187.34 | 7,870.03 | 4,482.30 |